Financials
- Market Capitalization 940.31 M
- Employee 93
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.75
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2458 | IMMX Immix Biopharma, Inc. - Common Stock | 13.94 USD | -2.59% | +2.05% | +64.58% | +506.09% | 997.26 M USD | ||
| 2472 | GERN Geron Corporation - Common Stock | 1.51 USD | -1.31% | -0.66% | +4.86% | +4.86% | 970.13 M USD | ||
| 2486 | ARDX Ardelyx, Inc. - Common Stock | 3.81 USD | -0.26% | -2.06% | -24.70% | -40.47% | 949.40 M USD | ||
| 2487 | DSGN Design Therapeutics, Inc. - Common Stock | 15.09 USD | -1.05% | +0.67% | +26.38% | +167.08% | 944.36 M USD |